Cargando…

Quality of life in patients with chordomas/chondrosarcomas during treatment with proton beam therapy

Introduction: Health-related quality of life (HQL) parameters have never been tested in patients having chondromas/chondrosarcomas who are being treated with protons. The aim of this study was to document changes in HQL of chordoma/chondrosarcoma patients treated with proton beam radiotherapy. Treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Srivastava, A., Vischioni, B., Fiore, M.R., Vitolo, V., Fossati, P., Iannalfi, A., Tuan, J.K.L., Orecchia, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2013
Materias:	Radiobiology and Clinics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3700519/ https://www.ncbi.nlm.nih.gov/pubmed/23824125 http://dx.doi.org/10.1093/jrr/rrt057

Ejemplares similares

Initial clinical experience with scanned proton beams at the Italian National Center for Hadrontherapy (CNAO)
por: Tuan, J., et al.
Publicado: (2013)

The Biological Basis for Enhanced Effects of Proton Radiation Therapy Relative to Photon Radiation Therapy for Head and Neck Squamous Cell Carcinoma
por: Wang, Li, et al.
Publicado: (2021)

Influence of chronic hypoxia and radiation quality on cell survival
por: Ma, Ning-Yi, et al.
Publicado: (2013)

Influence of acute hypoxia and radiation quality on cell survival
por: Tinganelli, Walter, et al.
Publicado: (2013)

Surgical spacer placement prior carbon ion radiotherapy (CIRT): an effective feasible strategy to improve the treatment for sacral chordoma
por: Cobianchi, Lorenzo, et al.
Publicado: (2016)

Erratum to: Surgical spacer placement prior carbon ion radiotherapy (CIRT): an effective feasible strategy to improve the treatment for sacral chordoma
por: Cobianchi, Lorenzo, et al.
Publicado: (2016)

Targeting Micrometastases: The Effect of Heterogeneous Radionuclide Distribution on Tumor Control Probability
por: Falzone, Nadia, et al.
Publicado: (2019)

γ-Tocotrienol–Loaded Liposomes for Radioprotection from Hematopoietic Side Effects Caused by Radiotherapeutic Drugs
por: Lee, Sang-gyu, et al.
Publicado: (2021)

Regulation of O(2) consumption by the PI3K and mTOR pathways contributes to tumor hypoxia
por: Kelly, Catherine J., et al.
Publicado: (2014)

Hadron therapy information sharing prototype
por: Roman, Faustin Laurentiu, et al.
Publicado: (2013)

Data-driven Markov models and their application in the evaluation of adverse events in radiotherapy
por: Abler, Daniel, et al.
Publicado: (2013)

Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression()
por: Groselj, Blaz, et al.
Publicado: (2013)

Short fractionation radiotherapy for early prostate cancer in the time of COVID-19: long-term excellent outcomes from a multicenter Italian trial suggest a larger adoption in clinical practice
por: Barra, Salvina, et al.
Publicado: (2020)

PET-Based Human Dosimetry of (68)Ga-NODAGA-Exendin-4, a Tracer for β-Cell Imaging
por: Boss, Marti, et al.
Publicado: (2020)

Immunotherapy for Chordoma and Chondrosarcoma: Current Evidence
por: Traylor, Jeffrey I., et al.
Publicado: (2021)

Dosimetric analysis of local failures in skull-base chordoma and chondrosarcoma following pencil beam scanning proton therapy
por: Basler, Lucas, et al.
Publicado: (2020)

Management of Chordoma and Chondrosarcoma with Fractionated Stereotactic Radiotherapy
por: Vasudevan, Harish N., et al.
Publicado: (2017)

Proton Therapy for Skull-Base Chordomas and Chondrosarcomas: Initial Results From the Beaumont Proton Therapy Center
por: Parzen, Jacob S, et al.
Publicado: (2021)

Proton therapy with a fixed beamline for skull-base chordomas and chondrosarcomas: outcomes and toxicity
por: Gordon, Konstantin, et al.
Publicado: (2021)

The preliminary results of proton and carbon ion therapy for chordoma and chondrosarcoma of the skull base and cervical spine
por: Guan, Xiyin, et al.
Publicado: (2019)

Pure proton therapy for skull base chordomas and chondrosarcomas: A systematic review of clinical experience
por: Nie, Menglin, et al.
Publicado: (2022)

Carbon Ion Radiotherapy: An Evidence-Based Review and Summary Recommendations of Clinical Outcomes for Skull-Base Chordomas and Chondrosarcomas
por: Holtzman, Adam L., et al.
Publicado: (2023)

Biological optimization for mediastinal lymphoma radiotherapy – a preliminary study
por: Rechner, Laura Ann, et al.
Publicado: (2020)

Application of failure mode and effects analysis to treatment planning in scanned proton beam radiotherapy
por: Cantone, Marie Claire, et al.
Publicado: (2013)

A study of histological features distinguishing chordoma from chondrosarcoma.
por: Byers, P. D.
Publicado: (1981)

Particle Beam Therapy Tolerance and Outcome on Patients with Autoimmune Diseases: A Single Institution Matched Case–Control Study
por: Riva, Giulia, et al.
Publicado: (2021)

Dosimetric Evaluation of the Effect of Receptor Heterogeneity on the Therapeutic Efficacy of Peptide Receptor Radionuclide Therapy: Correlation with DNA Damage Induction and In Vivo Survival
por: Tamborino, Giulia, et al.
Publicado: (2022)

Economics of the Management of Craniospinal Chordoma and Chondrosarcoma and the feasibility of the bundled payment model
por: Aljuboori, Zaid, et al.
Publicado: (2020)

Multimodal Intraoperative Image-Driven Surgery for Skull Base Chordomas and Chondrosarcomas
por: Essayed, Walid I., et al.
Publicado: (2022)

Carbon Ion Radiotherapy for Patients with Extracranial Chordoma or Chondrosarcoma - Initial Experience from Shanghai Proton and Heavy Ion Center
por: Wu, Shuang, et al.
Publicado: (2019)

Assessment of Radiation-Induced Optic Neuropathy in a Multi-Institutional Cohort of Chordoma and Chondrosarcoma Patients Treated with Proton Therapy
por: Köthe, Andreas, et al.
Publicado: (2021)

Zoledronic acid in metastatic chondrosarcoma and advanced sacrum chordoma: two case reports
por: Montella, Liliana, et al.
Publicado: (2009)

MRI-Based Radiomics Differentiates Skull Base Chordoma and Chondrosarcoma: A Preliminary Study
por: Yamazawa, Erika, et al.
Publicado: (2022)

Pancreatic cancer: Does a short course of carbon ion radiotherapy worth during COVID-19 outbreak?
por: Barcellini, Amelia, et al.
Publicado: (2020)

α-methylacyl-CoA racemase (AMACR) expression in chordomas differentiates them from chondrosarcomas
por: Aviel-Ronen, Sarit, et al.
Publicado: (2016)

Treatment of Chordomas and Chondrosarcomas With CyberKnife Robotic Hypofractionated Radiosurgery: A Single Institution Experience
por: Sallabanda, Morena, et al.
Publicado: (2021)

Dosimetric advantages of proton beam therapy compared to intensity-modulated radiation therapy for retroperitoneal chordoma
por: Yu, Nathan Y, et al.
Publicado: (2019)

Chordoma dedifferentiation after proton beam therapy: a case report and review of the literature
por: Frankl, Joseph, et al.
Publicado: (2016)

Dramatic Response of a Large Sacral Chordoma to Intensity Modulated Proton Beam Therapy
por: Schneider, Craig, et al.
Publicado: (2017)

The Role of Carbon Ion Therapy in the Changing Oncology Landscape—A Narrative Review of the Literature and the Decade of Carbon Ion Experience at the Italian National Center for Oncological Hadrontherapy
por: Orlandi, Ester, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nrj9g6mch07rfmr1326m05gh4g